Insmed | INSM - DETTE





DETTE Changement Date
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
DBV Technologies USD 6.1M 2.49M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 725.8M 1.82M 2026-06
Novartis USD 47B 14.98B 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06